Arcline Investment Management Sells Resolution Medical
Arcline Investment Management, a dynamic private equity firm, has made a notable move in the medical technology landscape. The firm is set to sell its portfolio company, Resolution Medical, to Resonetics. This strategic decision highlights Arcline's ongoing commitment to advancing innovative solutions within the medical devices sector.
About Resolution Medical
Resolution Medical, established in Minnesota, excels in providing comprehensive engineering services and outsourced manufacturing. Specializing in Class II and III medical devices, it plays a crucial role in various medical technology domains, including structural heart and neuromodulation therapies. Employing around 240 skilled professionals, the company boasts over 100 engineers renowned for their expertise in device design, prototyping, bio-simulation, and manufacturing processes.
Leadership Comments
Peter Herman, CEO of Resolution Medical, expressed enthusiasm about the acquisition, stating, "With Arcline's support, we have transformed into a leader in the development of groundbreaking medical devices, particularly in rapidly growing therapeutic areas. Joining Resonetics represents an exciting opportunity to further our mission of advancing interventional medicine technologies that save lives and enhance patient outcomes."
In response, Kevin Kelly, CEO of Resonetics, praised Resolution Medical's strengths, remarking, "This acquisition equips us with the capabilities to offer integrated solutions to our customers in burgeoning markets. We are thrilled to welcome such a high-caliber team and strengthen our commitment to innovation in the medical device industry."
Acquisition Timeline and Advisors
The transaction is projected to finalize in the early part of the year, pending regulatory clearances and standard closing criteria. This strategic acquisition comes with the advisory support from Piper Sandler & Co., which acted as the financial advisor, alongside legal representation from Bass, Berry & Sims PLC and Fredrikson & Byron P.A.
About Arcline Investment Management
Arcline Investment Management distinguishes itself as a growth-focused private equity firm overseeing assets exceeding $20 billion. The firm actively seeks to develop next-generation industrial enterprises—platforms designed to persistently enhance earnings over time. By fostering innovation and sustainability, Arcline aims to position itself as a leader in the industrial sector.
Contact Information
For further inquiries regarding Arcline Investment Management, their website offers comprehensive resources. Prospective clients and interested parties can visit www.arcline.com for more information.
Press inquiries can be directed to Tim Ragones or Alexander Wolfsohn at Joele Frank, Wilkinson Brimmer Katcher, available at the contact number (212) 355-4449.
Frequently Asked Questions
What is the significance of the acquisition?
The acquisition aims to enhance Resonetics' capabilities in delivering innovative solutions in the medical device field.
Who are the main players involved in this transaction?
Arcline Investment Management is overseeing the sale, while Resolution Medical is the company being sold to Resonetics.
What sectors does Resolution Medical serve?
Resolution Medical specializes in Class II and III devices and serves areas like cardiology and neuromodulation therapies.
When is the acquisition expected to close?
The acquisition is anticipated to close in the first quarter of the year, contingent on regulatory approvals.
How does Arcline Investment Management contribute to the industry?
Arcline focuses on building industrial platforms that consistently enhance earnings and promote innovative business practices in various sectors.
